Huennekens R Scott 4
4 · QuidelOrtho Corp · Filed Jun 2, 2026
Research Summary
AI-generated summary of this filing
QuidelOrtho (QDEL) Director R. Scott Huennekens Receives Award
What Happened
R. Scott Huennekens, a director of QuidelOrtho Corporation, had 6,829 restricted stock units (RSUs) vest on May 29, 2026 and those RSUs converted into 6,829 shares of common stock. The Form 4 reports an award/acquisition (code A) of 6,829 shares at $0.00 and a matching exercise/conversion of a derivative (code M) for 6,829 shares at $0.00 — reflecting release/settlement of RSUs with no cash paid.
Key Details
- Transaction date: May 29, 2026; Form 4 filed June 2, 2026.
- Reported entries: A — 6,829 shares @ $0.00 (acquired); M — 6,829 shares @ $0.00 (derivative conversion).
- Footnotes: F1 — release of RSUs previously reported; F2 — each RSU = one share; F3 — RSUs vested on May 29, 2026.
- Shares owned after transaction: not specified in the provided filing.
- Filing timeliness: Form filed June 2, 2026; no late-filing flag was indicated in the reported record.
Context
This was a routine equity-compensation event (RSU vesting and settlement), not an open-market purchase or sale. The M-code “disposition” here denotes conversion/settlement of the derivative (RSUs) into shares, not a public sale of stock. Such awards reflect compensation arrangements rather than an explicit insider buy or sell signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-29+6,829→ 9,352 total - Exercise/Conversion
Restricted Stock Units (Equity Grant)
[F2][F3]2026-05-29−6,829→ 0 total→ Common Stock (6,829 underlying)
Footnotes (3)
- [F1]Reflects release of restricted stock units that were previously reported on a Form 4.
- [F2]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
- [F3]The restricted stock units vested on May 29, 2026.